FP297ECULIZUMAB REDUCES BIOMARKER LEVELS RELATED TO THROMBOTIC MICROANGIOPATHY IN PATIENTS WITH ATYPICAL HAEMOLYTIC URAEMIC SYNDROME: CORRELATION TO RENAL FUNCTION IMPROVEMENT | Zendy

AI Assistant Blog Pricing

FP297ECULIZUMAB REDUCES BIOMARKER LEVELS RELATED TO THROMBOTIC MICROANGIOPATHY IN PATIENTS WITH ATYPICAL HAEMOLYTIC URAEMIC SYNDROME: CORRELATION TO RENAL FUNCTION IMPROVEMENT

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.